Insider Selling: Liquidia Technologies, Inc. (NASDAQ:LQDA) Insider Sells $38,170.44 in Stock

Liquidia Technologies, Inc. (NASDAQ:LQDA - Get Free Report) insider Sarah Krepp sold 2,673 shares of the firm's stock in a transaction dated Monday, July 14th. The shares were sold at an average price of $14.28, for a total value of $38,170.44. Following the completion of the transaction, the insider owned 142,499 shares in the company, valued at approximately $2,034,885.72. This represents a 1.84% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link.

Liquidia Technologies Stock Down 1.3%

Shares of NASDAQ LQDA traded down $0.20 during mid-day trading on Friday, reaching $14.41. 929,859 shares of the company's stock were exchanged, compared to its average volume of 1,301,913. The firm has a market capitalization of $1.23 billion, a price-to-earnings ratio of -9.14 and a beta of -0.01. The company has a current ratio of 2.93, a quick ratio of 2.91 and a debt-to-equity ratio of 2.08. The business has a fifty day simple moving average of $14.88 and a 200 day simple moving average of $14.48. Liquidia Technologies, Inc. has a twelve month low of $8.26 and a twelve month high of $19.41.

Liquidia Technologies (NASDAQ:LQDA - Get Free Report) last announced its earnings results on Thursday, May 8th. The company reported ($0.45) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.42) by ($0.03). The firm had revenue of $3.12 million during the quarter, compared to analyst estimates of $3.23 million. Liquidia Technologies had a negative net margin of 903.80% and a negative return on equity of 177.91%. As a group, equities analysts expect that Liquidia Technologies, Inc. will post -1.51 EPS for the current fiscal year.

Institutional Inflows and Outflows

Hedge funds have recently bought and sold shares of the stock. Vanguard Group Inc. boosted its stake in shares of Liquidia Technologies by 3.4% during the 4th quarter. Vanguard Group Inc. now owns 3,557,296 shares of the company's stock worth $41,834,000 after acquiring an additional 115,367 shares during the period. LM Advisors LLC bought a new position in shares of Liquidia Technologies during the 4th quarter worth approximately $25,948,000. Whitefort Capital Management LP boosted its stake in shares of Liquidia Technologies by 16.8% during the 4th quarter. Whitefort Capital Management LP now owns 1,987,245 shares of the company's stock worth $23,370,000 after acquiring an additional 285,220 shares during the period. Vestal Point Capital LP boosted its stake in shares of Liquidia Technologies by 17.3% during the 4th quarter. Vestal Point Capital LP now owns 1,760,000 shares of the company's stock worth $20,698,000 after acquiring an additional 260,000 shares during the period. Finally, Geode Capital Management LLC boosted its stake in shares of Liquidia Technologies by 8.2% during the 4th quarter. Geode Capital Management LLC now owns 1,339,254 shares of the company's stock worth $15,753,000 after acquiring an additional 101,597 shares during the period. 64.54% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

Several research firms recently issued reports on LQDA. HC Wainwright raised their price target on Liquidia Technologies from $29.00 to $35.00 and gave the company a "buy" rating in a report on Wednesday, May 28th. Wells Fargo & Company raised their price target on Liquidia Technologies from $23.00 to $25.00 and gave the company an "overweight" rating in a report on Thursday, June 12th. BTIG Research reiterated a "buy" rating on shares of Liquidia Technologies in a report on Tuesday, May 27th. Needham & Company LLC reiterated a "buy" rating on shares of Liquidia Technologies in a report on Monday, June 2nd. Finally, Raymond James Financial increased their target price on Liquidia Technologies from $27.00 to $29.00 and gave the company a "strong-buy" rating in a research note on Friday, May 9th. One equities research analyst has rated the stock with a sell rating, one has given a hold rating, six have assigned a buy rating and two have given a strong buy rating to the company's stock. According to data from MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and an average price target of $26.89.

About Liquidia Technologies

Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its lead product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD).